Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Sell
1,400
-12,700
-90% -$1.54M ﹤0.01% 2338
2026
Q1
$2.31M Buy
14,100
+11,700
+488% +$1.8M 0.01% 1305
2025
Q4
$418K Sell
2,400
-4,600
-66% -$839K ﹤0.01% 2167
2025
Q3
$1.01M Buy
+7,000
New +$858K ﹤0.01% 1840

Other funds holding INSM

PEAK6's INSM Position: Q2 2026 in Review

PEAK6 reduced its Insmed (INSM) stake by 22% in Q2 2026, selling an estimated $208K and leaving 6,209 shares worth $662K. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

PEAK6 first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.86M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • PEAK6 held 6,209 shares of Insmed worth $662K as of Q2 2026.
  • PEAK6 sold 1,717 Insmed shares in Q2 2026, an estimated $208K.
  • Insmed made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1859 holding.
  • PEAK6 first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • PEAK6's Insmed position peaked at $3.86M in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.